translate
Research News
IPF Research
Life with PF
COVID-19 Resources
Blog: PFF Insights
About PF
About IPF
Treatment Options
Clinical Trials Education Center
Maintaining Your Health
Oxygen Therapy
Find Medical Care
Find Support Groups
PFF Educational Resources
PFF Educational Videos
Pulmonary Rehabilitation Toolkit
Our Role
Who We Are
News & Media
Community Programs
Leadership
Financials
Contact Us
Career Opportunities
Get Involved
Attend an Event
Advocacy
Become a Sponsor
Broadway Belts for PFF
Plan a Fundraiser
PFF Walk
PF Awareness Month
Share Your Story
Shop at the PFF Store
Ways to Give
Donate Now
Honor a Loved One
Support PFF at Work
Donate Stocks and Bonds
Planned Giving
Medical Community
COVID-19 Resources
Blog: PFF Insights
PFF Research Funds
Partnership Grants
Sponsorship Opportunities
Leanne Storch Support Group Fund
PFF Summit
PFF Care Center Network
PFF Registry
Connect With Patients
CME/CE Library
Health Provider Resources
Sponsors and Exhibitors
Contact Us
join our
e
newsletter
|
translate
Join Our Monthly eNewsletter
Subscribe to receive the most current news and updates from the Pulmonary Fibrosis Foundation.
Life with PF
Education & Support
COVID-19 Resources
Blog: PFF Insights
About PF
About IPF
Treatment Options
Clinical Trials Education Center
Clinical Trials 101
PF Pipeline Glossary
Pipeline
Research News
IPF Research
Maintaining Your Health
Oxygen Therapy
Find Medical Care
Find Support Groups
Local and International
Online Support Communities
Support Group Leader Network
PFF Educational Resources
Webinars
Ask A Doc March 2015
Patient Education Materials
PF Community Resources
Life with Pulmonary Fibrosis
Advocacy in Action Webinar Series
PFF Educational Videos
Pulmonary Rehabilitation Toolkit
Our Role
Information & Programs
Who We Are
News & Media
News
Breathe Bulletin
Archive
Media Resources
PFF in the Media
Community Programs
PFF Care Center Network
PFF Patient Registry
PF Awareness Month
PFF Summit
PFF Help Center
PFF Oxygen Information Line
PFF Support Group Leader Network
PFF Ambassador Program
PFF Educational Videos
Leadership
Board of Directors
Stephen A. Wald
Stephen A. Wald
Joseph Borus
Stephen A. Wald
Medical Advisory Board
Research Review Committee
Medical and Scientific Advisory Committee
Financials
Contact Us
Career Opportunities
Get Involved
Events & Awareness
Attend an Event
Advocacy
Become a Sponsor
Broadway Belts for PFF
Plan a Fundraiser
PFF Walk
PF Awareness Month
Share Your Story
Shop at the PFF Store
Ways to Give
Donations & Tributes
Donate Now
Honor a Loved One
Create or Donate to an Online Tribute/Memorial
Set Up Memorial Contributions
Celebrate Lifetime Events
Support PFF at Work
Donate Stocks and Bonds
Planned Giving
Medical Community
Research & Resources
COVID-19 Resources
Blog: PFF Insights
PFF Research Funds
I.M. Rosenzweig Junior Investigator Award
Albert Rose Established Investigator Award
PFF Scholars
Partnership Grants
Sponsorship Opportunities
Leanne Storch Support Group Fund
PFF Summit
PFF Care Center Network
PFF Registry
Statements-HRCT
Statements-HRCT
Connect With Patients
Patient Education Materials
Host an Event
Support Groups
PFF Ambassador Program
CME/CE Library
Health Provider Resources
Stem Cell/Cell-Based Therapies for Pulmonary Fibrosis
Role of Surgical Lung Biopsy in ILD
HRCT Position Statement
Familial Pulmonary Fibrosis for Patients
Familial Pulmonary Fibrosis for Health Care Providers
Donate
Home
>
Life with PF
>
Clinical Trials Education Center
>
Pipeline
>
IPF Research
A
A
COVID-19 Resources
Blog: PFF Insights
About PF
About IPF
Treatment Options
Clinical Trials Education Center
Clinical Trials 101
PF Pipeline Glossary
Pipeline
Maintaining Your Health
Oxygen Therapy
Find Medical Care
Find Support Groups
Local and International
Online Support Communities
Support Group Leader Network
PFF Educational Resources
Webinars
Patient Education Materials
PF Community Resources
Life with Pulmonary Fibrosis
Advocacy in Action Webinar Series
PFF Educational Videos
Pulmonary Rehabilitation Toolkit
IPF Research
See below for the latest in research news related to Idiopathic Pulmonary Fibrosis (IPF). This is where the PFF will share relevant news articles, press releases, and study results in the field of IPF.
The pulmonary fibrosis treatment landscape: An interview with an expert
by Brian Buntz
Mar 17, 2021
Full story
: The pulmonary fibrosis treatment landscape: An interview with an expert
Genentech’s Actemra Becomes the First Biologic Therapy Approved by the FDA for Slowing the Rate of Decline in Pulmonary Function in Adults With Systemic Sclerosis-Associated Interstitial Lung Disease, a Rare, Debilitating Condition
by Kelsey Overberg
Mar 5, 2021
Full story
: Genentech’s Actemra Becomes the First Biologic Therapy Approved by the FDA for Slowing the Rate of Decline in Pulmonary Function in Adults With Systemic Sclerosis-Associated Interstitial Lung Disease, a Rare, Debilitating Condition
CR Pharma NIP292 tablets received Orphan Drug Designation issued by FDA
by Kelsey Overberg
Feb 16, 2021
Full story
: CR Pharma NIP292 tablets received Orphan Drug Designation issued by FDA
$22M NIH Grant Supports Precision Medicine for Pulmonary Fibrosis
by Health IT Analytics
Feb 10, 2021
Full story
: $22M NIH Grant Supports Precision Medicine for Pulmonary Fibrosis
Driving research and awareness of pulmonary fibrosis: Pulmonary Fibrosis Foundation is leading the path to a cure
by American Journal of Physiology | Lung Cellular and Molecular Physiology
Feb 10, 2021
Full story
: Driving research and awareness of pulmonary fibrosis: Pulmonary Fibrosis Foundation is leading the path to a cure
Pulmonary Fibrosis Foundation Announces New Sponsorship by United Therapeutics
by Newswire
Feb 10, 2021
Full story
: Pulmonary Fibrosis Foundation Announces New Sponsorship by United Therapeutics
Spotlight on the Impact of Precision Medicine in Clinical Trial Development
by ACRPtv
Feb 10, 2021
Full story
: Spotlight on the Impact of Precision Medicine in Clinical Trial Development
Galapagos and Gilead discontinue ISABELA Phase 3 trials in IPF
by Kelsey Overberg
Feb 10, 2021
Full story
: Galapagos and Gilead discontinue ISABELA Phase 3 trials in IPF
Coronavirus (COVID-19) Update: FDA Authorizes Drug Combination for Treatment of COVID-19
by Kelsey Overberg
Feb 5, 2021
Full story
: Coronavirus (COVID-19) Update: FDA Authorizes Drug Combination for Treatment of COVID-19
Baricitinib Receives Emergency Use Authorization from the FDA for the Treatment of Hospitalized Patients with COVID-19
by Kelsey Overberg
Feb 5, 2021
Full story
: Baricitinib Receives Emergency Use Authorization from the FDA for the Treatment of Hospitalized Patients with COVID-19
Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19
by Kelsey Overberg
Feb 5, 2021
Full story
: Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19
FDA’s approval of Veklury (remdesivir) for the treatment of COVID-19—The Science of Safety and Effectiveness
by Kelsey Overberg
Feb 5, 2021
Full story
: FDA’s approval of Veklury (remdesivir) for the treatment of COVID-19—The Science of Safety and Effectiveness
Clinical Trial Will Evaluate Saracatinib in Idiopathic Pulmonary Fibrosis
by Kelsey Overberg
Feb 5, 2021
Full story
: Clinical Trial Will Evaluate Saracatinib in Idiopathic Pulmonary Fibrosis
US FDA grants saracatinib Orphan Drug Designation for idiopathic pulmonary fibrosis
by Kelsey Overberg
Feb 5, 2021
Full story
: US FDA grants saracatinib Orphan Drug Designation for idiopathic pulmonary fibrosis
First Patient Enrolls In PRECISIONS Study For Treatment Of Idiopathic Pulmonary Fibrosis
by Kelsey Overberg
Jan 11, 2021
Full story
: First Patient Enrolls In PRECISIONS Study For Treatment Of Idiopathic Pulmonary Fibrosis
Phase 3 trial of Novavax investigational COVID-19 vaccine opens
by Kelsey Overberg
Dec 29, 2020
Full story
: Phase 3 trial of Novavax investigational COVID-19 vaccine opens
FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine
by Kelsey Overberg
Dec 21, 2020
Full story
: FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate
by Kelsey Overberg
Dec 18, 2020
Full story
: Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate
Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study
by Kelsey Overberg
Dec 18, 2020
Full story
: Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study
Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints
by Kelsey Overberg
Dec 18, 2020
Full story
: Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints
1
(current)
2
3
4
5
6